Annexon Biosciences

280 Utah Avenue
Suite 110
South San Francisco
California
94080
United States

Tel: 650-822-5500

Email: info@annexonbio.com

Show jobs for this employer

About Annexon Biosciences


Annexon Biosciences is leading the development of therapeutic products that halt the progression of CMND. Our antibody pipeline is based on breakthrough research involving the classical complement pathway and the unique role of its initiating molecule, C1q, in triggering the loss of nerve connections and inducing inflammation in neurologic and ophthalmic disorders.

YEAR FOUNDED:

August 2011

LEADERSHIP:

CEO: Douglas Love, Esq

Chief Scientific Officer: Ted Yednock, PhD

Chief Medical Officer: Mario Saltarelli, MD, PhD

7 articles with Annexon Biosciences